ATE484520T1 - Antitumorheilmittel, medikament, zusammensetzung und verwendung davon - Google Patents

Antitumorheilmittel, medikament, zusammensetzung und verwendung davon

Info

Publication number
ATE484520T1
ATE484520T1 AT07290440T AT07290440T ATE484520T1 AT E484520 T1 ATE484520 T1 AT E484520T1 AT 07290440 T AT07290440 T AT 07290440T AT 07290440 T AT07290440 T AT 07290440T AT E484520 T1 ATE484520 T1 AT E484520T1
Authority
AT
Austria
Prior art keywords
medication
composition
antitumor medicine
seq
acid sequence
Prior art date
Application number
AT07290440T
Other languages
English (en)
Inventor
Sylvie Colin
Salman Al-Mahmood
Original Assignee
Gene Signal Int Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gene Signal Int Sa filed Critical Gene Signal Int Sa
Application granted granted Critical
Publication of ATE484520T1 publication Critical patent/ATE484520T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07290440T 2007-04-11 2007-04-11 Antitumorheilmittel, medikament, zusammensetzung und verwendung davon ATE484520T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07290440A EP1980571B1 (de) 2007-04-11 2007-04-11 Antitumorheilmittel, Medikament, Zusammensetzung und Verwendung davon

Publications (1)

Publication Number Publication Date
ATE484520T1 true ATE484520T1 (de) 2010-10-15

Family

ID=38462232

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07290440T ATE484520T1 (de) 2007-04-11 2007-04-11 Antitumorheilmittel, medikament, zusammensetzung und verwendung davon

Country Status (3)

Country Link
EP (1) EP1980571B1 (de)
AT (1) ATE484520T1 (de)
DE (1) DE602007009797D1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001509679A (ja) * 1997-01-21 2001-07-24 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド レセプターをコードするポリヌクレオチドとポリペプチド
JP2004512832A (ja) * 2000-09-01 2004-04-30 バイオアクタ・リミテッド 抗−血管新生ペプチド
FR2836687A1 (fr) * 2002-03-04 2003-09-05 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
EP1570078A4 (de) * 2002-10-04 2006-09-13 Van Andel Res Inst Molekulare subklassifizierung von nierentumoren und entdeckung neuer diagnostischer marker
WO2005079766A2 (en) * 2004-02-20 2005-09-01 Novo Nordisk A/S Therapeutic combination comprising a tissue factor antagonist and anti-cancer compounds

Also Published As

Publication number Publication date
EP1980571A1 (de) 2008-10-15
DE602007009797D1 (de) 2010-11-25
EP1980571B1 (de) 2010-10-13
HK1123813A1 (en) 2009-06-26

Similar Documents

Publication Publication Date Title
IN2012DN02981A (de)
NZ598348A (en) Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
NZ595063A (en) Polypeptides from neisseria meningitidis
BR112014007069A2 (pt) proteínas de fusão para o tratamento de distúrbios metabólicos
WO2011036442A3 (en) Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders
NZ627111A (en) Variants of activin iib receptor polypeptides and uses thereof
PE20120358A1 (es) Mutantes fgf21 y usos de los mismos
PT2121731E (pt) Vacinas peptídicas para cancros que expressam antigénios associados a tumores
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
EP2476697A3 (de) Peptidvakzinen für MPHOSPH1- oder DEPDC1-Polypeptide exprimierenden Krebs
NZ600690A (en) Fkbp-l and uses thereof
ES2668967T3 (es) Inmunógenos de Escherichia coli con solubilidad mejorada
NZ602943A (en) Modified binding proteins inhibiting the vegf-a receptor interaction
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
ATE509096T1 (de) Von sparc abgeleitetes krebsabstossungsantigenpeptid und pharmazeutikum, das dieses enthält
RU2015118580A (ru) НОВЫЙ ВЫСОКО ФУНКЦИОНАЛЬНЫЙ ФЕРМЕНТ, ИМЕЮЩИЙ МОДИФИЦИРОВАННУЮ СУБСТРАТНУЮ СПЕЦИФИЧНОСТЬ β-ГЕКСОЗАМИНИДАЗЫ ЧЕЛОВЕКА И ПРОЯВЛЯЮЩИЙ УСТОЙЧИВОСТЬ К ПРОТЕАЗЕ
NZ708091A (en) Stabilized insulin-like growth factor polypeptides
EP2589658A4 (de) Teilbereichspolypeptid des reic/dkk-3 proteins
NZ703514A (en) Fviii peptides for immune tolerance induction and immunodiagnostics
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
NZ594268A (en) Grass peptides for vaccine
MX2009007261A (es) Vacuna de peptido foxp3.
ATE552271T1 (de) Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon
CY1111630T1 (el) Παραγωγα κυτοκινων
MX2010005816A (es) Epítopos de péptido de stat3.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties